Fever and rash in a returned traveler with thrombocytopenia

Prioritized differential

1. Dengue fever (with warning signs - see below)
2. Malaria (especially P. falciparum, given incomplete prophylaxis)
3. Typhoid fever
4. Leptospirosis
5. Chikungunya / Zika
6. Rickettsial infection (scrub typhus, murine typhus)
7. Meningococcemia (less likely given rash character and travel, but must be considered)

Features favoring dengue

• Acute high fever with severe retro-orbital headache and myalgia - classic dengue symptom triad.
• Blanching maculopapular rash with timing around defervescence.
• Thrombocytopenia with rising hematocrit (44% vs baseline 38%) - suggests plasma leakage, a hallmark of dengue with warning signs.
• Positive tourniquet test and mucosal bleeding (gum bleeding) - consistent with dengue hemorrhagic physiology.
• Leukopenia (WBC 3.1) - dengue typically causes leukopenia, whereas bacterial infections often cause leukocytosis.
• Transaminitis with AST > ALT - typical of dengue.

Features arguing against alternatives

• Malaria: doxycycline non-adherence makes it possible, but the rash and leukopenia are atypical; malaria usually lacks a maculopapular rash and often shows normal or low WBC with anemia. Must still exclude with thick and thin films and a rapid diagnostic test.
• Typhoid: relative bradycardia and rose spots are classic, but the rash here is diffuse and the patient is tachycardic; still, blood cultures are needed.
• Leptospirosis: often has conjunctival suffusion, calf tenderness, and renal/hepatic involvement; possible but less likely without exposure history.
• Rickettsial: eschar may be absent; doxycycline would have partially covered this.

Key point: The combination of thrombocytopenia, hemoconcentration, bleeding, and leukopenia after travel to Southeast Asia makes dengue with warning signs the leading diagnosis, but malaria must be excluded urgently because it is rapidly fatal and treatable.

This is dengue with warning signs progressing toward severe dengue (plasma leakage phase).

Monitoring

• Serial hematocrit and platelet counts every 4-6 hours during the critical phase.
• Vital signs and urine output hourly; watch for hypotension, narrow pulse pressure, and oliguria.
• Signs of shock: cool extremities, delayed capillary refill, rising hematocrit with falling BP.
• Liver enzymes and coagulation profile; monitor for bleeding.
• Repeat malaria testing if any doubt.

Management

• Fluid resuscitation with isotonic crystalloid (0.9% saline or Ringer's lactate) - start with 5-10 mL/kg/hour and titrate to urine output 0.5-1 mL/kg/hour and stable hematocrit. Avoid over-resuscitation once leakage subsides.
• Monitor for fluid overload (pulmonary edema) especially during the recovery phase when reabsorption occurs.
• Platelet transfusion is NOT routinely indicated for thrombocytopenia alone; reserve for significant bleeding with very low platelets, or before invasive procedures.
• Avoid NSAIDs and aspirin - they worsen bleeding.
• Avoid intramuscular injections where possible.
• Do not give corticosteroids or IVIG - no proven benefit.
• Do not use hypotonic fluids - risk of hyponatremia and cerebral edema.

Escalation

• If shock develops (compensated or hypotensive), escalate to bolus crystalloid 10-20 mL/kg and consider colloids if refractory; involve critical care.
• Blood products (fresh frozen plasma, packed cells) only for significant hemorrhage.

Disposition

• Admit to a monitored bed; the critical phase is typically around defervescence (days 3-7 of illness).

Response: platelet transfusion is not indicated for asymptomatic thrombocytopenia in dengue and may be harmful.

Evidence and rationale

• Thrombocytopenia in dengue is due to increased destruction and bone marrow suppression, and transfused platelets are cleared rapidly; the count rise is transient and does not prevent bleeding.
• Randomized trials (e.g., studies of prophylactic platelet transfusion in dengue) have not shown reduced bleeding compared with no transfusion, and some suggest increased adverse events.
• Risks include transfusion reactions, fluid overload (especially during plasma leakage), alloimmunization, and infection transmission.
• Bleeding in dengue is multifactorial - endothelial dysfunction, coagulopathy, and platelet dysfunction - so raising the number alone does not correct the underlying problem.

When transfusion IS considered

• Significant clinical bleeding (e.g., GI hemorrhage, intracranial bleed) with very low platelets.
• Before urgent invasive procedures in selected cases.
• Platelet count <10-20 ×10⁹/L with active bleeding - individualized decision with hematology input.

Communication with the patient

• Explain that the low platelet count is expected and usually recovers within days after the critical phase.
• Advise warning signs to return: persistent vomiting, abdominal pain, bleeding gums, black stools, lethargy, cold extremities.
• Avoid NSAIDs and aspirin; use paracetamol for fever.
• Follow-up platelet count in 24-48 hours; most patients recover without intervention.